Corsair Capital Management, L.P.
Source: SEC Form 13F · as of Mar 2026Corsair Capital Management, L.P. holds 9 biotech & pharma companies tracked by BioSniper, totaling $4.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$4.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 350,000 | $1.2M |
| HALOHALOZYME THERAPEUTICS, INC. | 10,000 | $646K |
| LQDALiquidia Corp | 15,000 | $566K |
| IQVIQVIA Holdings Inc. | 2,943 | $502K |
| ASRTAssertio Holdings, Inc. | 25,549 | $487K |
| PRVBPROVENTION BIO, INC. | 43,495 | $481K |
| AQSTAquestive Therapeutics, Inc. | 70,000 | $291K |
| MAIAMAIA Biotechnology, Inc. | 100,000 | $140K |
| RMTIROCKWELL MEDICAL, INC. | 50,000 | $45K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.